These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 2063979

  • 1. [Treatment of cardiogenic shock with exclusion of inotropic drugs].
    Lançon JP, Volot F, Beaufils C, Caillard B.
    Agressologie; 1991; 32(1):35-6. PubMed ID: 2063979
    [Abstract] [Full Text] [Related]

  • 2. Percutaneous left ventricular assist devices for treatment of patients with cardiogenic shock.
    Windecker S.
    Curr Opin Crit Care; 2007 Oct; 13(5):521-7. PubMed ID: 17762230
    [Abstract] [Full Text] [Related]

  • 3. Pharmacologic support in cardiogenic shock.
    Rude RE.
    Adv Shock Res; 1983 Oct; 10():35-49. PubMed ID: 6349299
    [Abstract] [Full Text] [Related]

  • 4. Intra-aortic balloon counterpulsation as a therapy for shock.
    Schott KE.
    Crit Care Nurs Clin North Am; 1990 Jun; 2(2):187-93. PubMed ID: 2357321
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M, Plank C, Meissner U, Eberle KP, Weyand M, Cesnjevar R, Dötsch J, Rascher W.
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Seven years' experience with the Pierce-Donachy ventricular assist device.
    Pennington DG, Kanter KR, McBride LR, Kaiser GC, Barner HB, Miller LW, Naunheim KS, Fiore AC, Willman V.
    J Thorac Cardiovasc Surg; 1988 Dec; 96(6):901-11. PubMed ID: 3057290
    [Abstract] [Full Text] [Related]

  • 10. [Modern aspects of cardiogenic shock].
    Weber H, Zilcher H.
    Z Gesamte Inn Med; 1983 Mar 01; 38(5):133-43. PubMed ID: 6858274
    [Abstract] [Full Text] [Related]

  • 11. Long-term survival using intra-aortic balloon pump and percutaneous right ventricular assist device for biventricular mechanical support of cardiogenic shock.
    Atwater BD, Nee LM, Gimelli G.
    J Invasive Cardiol; 2008 Jul 01; 20(7):E205-7. PubMed ID: 18599903
    [Abstract] [Full Text] [Related]

  • 12. [Cardiac insufficiency in recent myocardial infarct].
    Bourdarias JP.
    Rev Prat; 2008 Jul 01; 24(55):4993-4, 4999-5000, 5003-4 passim. PubMed ID: 4280621
    [No Abstract] [Full Text] [Related]

  • 13. Percutaneous ventricular assist device support during off-pump surgical coronary revascularization.
    Gregoric ID, Poglajen G, Span M, Frazier OH, Loyalka P, Kar B.
    Ann Thorac Surg; 2008 Aug 01; 86(2):637-9. PubMed ID: 18640347
    [Abstract] [Full Text] [Related]

  • 14. Initial experiences with the Impella device in patients with cardiogenic shock - Impella support for cardiogenic shock.
    Meyns B, Dens J, Sergeant P, Herijgers P, Daenen W, Flameng W.
    Thorac Cardiovasc Surg; 2003 Dec 01; 51(6):312-7. PubMed ID: 14669126
    [Abstract] [Full Text] [Related]

  • 15. Diagnosis and management of cardiogenic pulmonary edema.
    Alwi I.
    Acta Med Indones; 2010 Jul 01; 42(3):176-84. PubMed ID: 20973297
    [Abstract] [Full Text] [Related]

  • 16. [Synergic effects of intra-aortic counterpulsation and dopamine in experimental cardiogenic shock with closed thorax].
    Malpartida F, Muguerza I, Martínez-Caro D.
    Arch Inst Cardiol Mex; 1976 Jul 01; 46(3):295-304. PubMed ID: 1088853
    [Abstract] [Full Text] [Related]

  • 17. Use of the percutaneous left ventricular assist device in patients with severe refractory cardiogenic shock as a bridge to long-term left ventricular assist device implantation.
    Idelchik GM, Simpson L, Civitello AB, Loyalka P, Gregoric ID, Delgado R, Kar B.
    J Heart Lung Transplant; 2008 Jan 01; 27(1):106-11. PubMed ID: 18187095
    [Abstract] [Full Text] [Related]

  • 18. Management of cardiogenic shock attributable to acute myocardial infarction in the reperfusion era.
    Duvernoy CS, Bates ER.
    J Intensive Care Med; 2005 Jan 01; 20(4):188-98. PubMed ID: 16061902
    [Abstract] [Full Text] [Related]

  • 19. Hemodynamic effects of sulmazol (ARL-115 BS), a new vasodilator and positive inotropic agent, in patients with cardiogenic shock.
    Simoons ML, Muskens G, Hugenholtz PG.
    Herz; 1983 Feb 01; 8(1):34-40. PubMed ID: 6832691
    [Abstract] [Full Text] [Related]

  • 20. [Percutaneous insertion of a left ventricular assist device for cardiogenic shock in a patient with a myocardial infarction].
    Ottervanger JP, de Feijter P, Gardien M, Serruys PW.
    Ned Tijdschr Geneeskd; 2003 Jan 25; 147(4):164-6. PubMed ID: 12635549
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.